CCN2 and renal fibrosis: QYYY granules can also counter renal fibrosis by inhibiting the production of TGF-β [15], regulating the AngII-AT1R-CTGF pathway [13], and repressing the NF-κB inflammation pathway and the expression of NOX4 [12].